NB-001(Nanobio)

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameNB-001(Nanobio)
Drug Alias NameHerpes labialis therapy - NanoBioNanoHPXNB-001 (NanoBio Corporation)HTS-09836
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsHerpes Labialis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNanobio Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanobio CoBluewillow Biologics Inc
Active IndicationsN/A
Inactive IndicationsHerpes Labialis

Other Information

ATC CodeN/A
Related LinksN/A